healthcare-expenditure

Image for Doctors in England to consider if new offer is enough to end strikesHeadlines

Doctors in England to Consider if New Offer Is Enough to End Strikes

Image for US Medicare price cuts manageable for most drugmakers, analysts sayFinance

US Medicare Price Cuts Manageable for Most Drugmakers, Analysts Say

Image for Pope's visit is a blessing for Lebanon's forgotten psychiatric patientsFinance

Pope's Visit Is a Blessing for Lebanon's Forgotten Psychiatric Patients

Image for Dutch prosecutors relate 49 deaths to illegal medicines webshopHeadlines

Dutch Prosecutors Relate 49 Deaths to Illegal Medicines Webshop

Image for England's junior doctors to begin five-day walkout

England's Junior Doctors to Begin Five-Day Walkout

Date: November 14, 2025

LONDON (Reuters) -Junior doctors in England will begin strike action on Friday over concerns about job insecurity and pay erosion, with their union saying the government could still avert the walkout...

Image for Novo Nordisk, Lilly shares slip on US drug pricing deal

Novo Nordisk, Lilly Shares Slip on US Drug Pricing Deal

Date: November 7, 2025

By Jacob Gronholt-Pedersen and Maggie Fick COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3% on Friday after the Danish drugmaker and U.S. rival Eli Lilly agreed with the U.S. government...

Image for Novo Nordisk, Lilly strike deal with Trump to slash weight-loss drug prices

Novo Nordisk, Lilly Strike Deal With Trump to Slash Weight-Loss Drug Prices

Date: November 6, 2025

(Reuters) -Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House deal that would reduce prices of their blockbuster weight-loss treatments in...

Image for Novo Nordisk strikes US Medicare price deal

Novo Nordisk Strikes US Medicare Price Deal

Date: November 5, 2025

LONDON (Reuters) -Novo Nordisk said on Wednesday it has accepted the U.S. Inflation Reduction Act (IRA)'s maximum fair price for its diabetes and obesity medicines Ozempic, Wegovy and Rybelsus, which...

Image for GSK cancer, HIV drug sales lift 2025 outlook in boost for shares

Gsk Cancer, Hiv Drug Sales Lift 2025 Outlook in Boost for Shares

Date: October 29, 2025

(Reuters) -GSK raised its 2025 sales expectations on Wednesday, helped by double-digit growth in the third-quarter in its specialty medicines, including HIV and oncology.  The drugmaker expects...

Image for Sanofi notes 'negative buzz' around vaccines as profit beats forecasts

Sanofi Notes 'negative Buzz' Around Vaccines as Profit Beats Forecasts

Date: October 24, 2025

LONDON (Reuters) -France's Sanofi reported a third-quarter profit that beat analysts' expectations on Friday, boosted by strong demand for its anti-inflammatory drug Dupixent and newer medicines. It...